1. Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
   Coskun Ozer Demirtas et al, 2021, World Journal of Gastroenterology CrossRef
2. Predictive Factors for Hepatocellular Carcinoma Development after Direct-Acting Antiviral Treatment of HCV
   Zuzana Macek Jilkova et al, 2021, Livers CrossRef
3. Prediction and surveillance of de novo HCC in patients with compensated advanced chronic liver disease after hepatitis C virus eradication with direct antiviral agents
   Ashraf Elbahrawy et al, 2023, Frontiers in Virology CrossRef
4. Diabetes Mellitus Increases the Risk of Hepatocellular Carcinoma After Direct-Acting Antiviral Therapy: Systematic Review and Meta-Analysis
   Szilárd Váncsa et al, 2021, Frontiers in Medicine CrossRef
5. A Novel Standard for Hepatocellular Carcinoma Screening Intensity After Hepatitis C Elimination
   Akio Miyasaka et al, 2021, International Journal of General Medicine CrossRef
6. Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma
   Saleh A. Alqahtani et al, 2021, Cells CrossRef
7. Efforts to identify HCV antibody-positive patients in a medium-sized hospital by "Team hepatitis" composed of hospital staff with a hepatitis medical care coordinator
   Joji Tani et al, 2021, Kanzo CrossRef
8. Predicting Hepatocellular Carcinoma Risk in Patients with Chronic HCV Infection and a Sustained Virological Response to Direct-Acting Antivirals
   Roberta D'Ambrosio et al, 2021, Journal of Hepatocellular Carcinoma CrossRef
9. Risk of hepatocellular carcinoma after hepatitis C virus cure
   Maria Alejandra Luna-Cuadros et al, 2022, World Journal of Gastroenterology CrossRef
10. Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?
    Francesco Paolo Russo et al, 2022, International Journal of Molecular Sciences CrossRef
11. Revolution in the diagnosis and management of hepatitis C virus infection in current era
    F M Hanif et al, 2022, World Journal of Hepatology CrossRef
12. Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate
    Ahmed Kamal et al, 2022, World Journal of Clinical Cases CrossRef
13. Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A debate near the end
    Cristina Maria Muzica et al, 2020, World Journal of Gastroenterology CrossRef